- Artificial intelligence (AI) and healthcare access remain key
themes at ISMRM as researchers and clinicians seek more efficient
and effective solutions in today’s resource-constrained
environment
- GE Healthcare highlights the continued expansion of its
state-of-the-art AIR Recon DL technology across the totality of its
1.5T, 3.0T and 7.0T MR product portfolio
- Already, this democratization of AI has benefitted more than
two million patients around the world and fundamentally shifted the
balance between image quality and scan time in MR
At the International Society for Magnetic Resonance in Medicine
(ISMRM) 2022 Annual Meeting, GE Healthcare boasts the continued
expansion of its pioneering deep learning image reconstruction
solution, AIR Recon DL, to its tens of thousands of install base
customers as an upgrade as well as with new purchases across its MR
product portfolio. This marks a significant moment in the
democratization of artificial intelligence (AI) and deep learning
for the benefit of healthcare systems and patients around the
world.
Imaging more than 200 million patients in 2021i, MR plays an
increasingly important role in precision diagnostics, helping
clinicians detect neurodegenerative diseases, cancer, heart
conditions, and other diseases large and small. However,
discrepancies in access to certain MR advancements can have a
significant impact on the availability and quality of care
clinicians can deliver to patients.
“Since we first saw the power of our AI-based deep learning
image reconstruction technology, AIR Recon DL, we knew it could
have a massive clinical impact. So, we went all in,” says Jie Xue,
President & CEO, Magnetic Resonance, GE Healthcare. “We
developed it for all anatomies; we made it work on all field
strengths – 1.5T, 3.0T and 7.0T – and most importantly, we made it
available not only on our latest scanner models, but also on all
our installed GE MR scanners dating back 20+ years. From first time
MR users to experienced MR researchers, we want every GE MR
customer – regardless of their scanner’s age – to benefit from
today’s groundbreaking AI-based technology.”
To date, AIR Recon DL has benefitted more than two million
patients around the world, with overwhelmingly positive feedback
from clinicians, who celebrate sharper and less noisy images for a
more confident patient diagnosis as well as up to a 50% reduction
in exam times for a more comfortable patient experienceii. To build
on this success, GE Healthcare announced the continued expansion of
AIR Recon DL, which was developed on GE Healthcare’s Edison
intelligence platform, to include the motion-insensitive sequence
PROPELLER and 3D applicationsiii. With this expansion, AIR Recon DL
covers nearly 90 percent of clinical MR sequences, regardless of
the anatomy being scanned.
These advancements have proved especially valuable for those who
struggle to remain still during MR exams, such as pediatric,
neurodegenerative and geriatric patients. Dr. Shreyas Vasanawala,
Chief of Pediatric Radiology & Director of MRI, Lucile Packard
Children’s Hospital at Stanford shares: “Patients don’t necessarily
know that this feature is being turned on or off. But they wind up
just seeing that their appointment has gone quicker, and for a lot
of children we’re just able to get the scan done before they’ve
reached their limit of cooperation.”
In addition to a faster and more comfortable patient experience,
AIR Recon DL helps to provide more confident patient diagnosis. Dr.
Hollis Potter, Chair of Radiology, Hospital for Special Surgery
comments: “There is more detail in the image, especially at a lower
matrix. In some conventionally processed MR images, the trabecular
bone pattern is poor, the nerves are blurred and there is a lot of
noise in the image. With AIR Recon DL, the difference is
striking.”
AIR Recon DL offers greater efficiency to healthcare systems.
The AI-based algorithm has been the subject of more than 12
international, peer-reviewed scientific journal publications
covering various anatomies, with conclusions underlining the
reliability, efficiency, and utility of deep learning-based
enhancement for quantitative imaging across care pathways.
Radiology departments today continue to face multiple challenges –
including increased workload demands due to a backlog of cases
resulting from COVID-19, steadily growing patient volumes, and
industry-wide staff shortages and burnoutiv,v. As a result, there
is clear need for broad access to MR clinical solutions that can
reduce time-to-diagnosis, improve patient throughput, and enhance
the patient and staff experience.
To this end, GE Healthcare is proud to showcase more than a
dozen additional innovative MR solutions at ISMRM to help
clinicians tackle today’s challenging healthcare demands while also
improving access and providing more personalized, quality care.
This includes several solutions developed to help provide precision
healthcare to even the most challenging patients:
Prostate Cancer Patients: Prostate
cancer is the second most commonly occurring cancer in men and the
fourth most common cancer overallvi. While traditional prostate
imaging exams can be uncomfortably invasive and complex, AIR Coils
are lightweight and flexible, closely wrapping around patients,
like a blanket, and offering incredible image quality. Combined
with AIR Recon DL, AIR Coils push the limit on signal-to-noise
ratio (SNR) and sharpness with 50% less scan time while meeting
PI-RADS standards for a faster, more comfortable and less invasive
patient experience.
Pregnant Mothers & Children: As an
alternative when ionizing radiation is a concern, GE Healthcare
offers oZTEo, an MR bone imaging solution that provides CT-like
image contrast for both soft tissue assessment and bone imaging
within the same exam. This can lessen the burden on the patient to
attend two separate imaging modality appointments and may also lead
to reduced healthcare costs.
Neurodegenerative Patients:
Individuals with neurodegenerative disorders – such as Alzheimer’s,
Huntington’s or Parkinson’s Disease – often struggle to remain
still during lengthier exams. In response, GE Healthcare designed
its proprietary MotionFree Brainvii on its SIGNA PET/MR to provide
significant improvement in quantitative accuracy – especially for
small brain lesions – and a more comfortable scanning experience
for patients.
Claustrophobic & Obese Patients:
For larger sized patients or those who struggle with
claustrophobia, GE Healthcare offers SIGNA Evoviii, which is
designed to enable healthcare systems to transform their legacy
3.0T and 1.5T 60 cm narrow bore MR systems to premium,
state-of-the-art 3.0T and 1.5T, 70 cm wide bore systems – helping
them accommodate more patients of all shapes and sizes. For
healthcare systems, this solution also would transform the existing
system’s magnet, with the goal of enabling 40 percent faster return
on investment (ROI) potential over replacing the whole
systemix.
Altogether, GE Healthcare is proud to usher in ‘A Bold New World
in MR’ – one which is focused on the development and increased
availability of innovative technologies and solutions to MR users
for the benefit of clinicians and patients around the world.
For more information on GE Healthcare’s MR portfolio, see
gehealthcare.com or visit the company’s #ISMRM22 booth or virtual
platform.
About GE Healthcare:
GE Healthcare is the $17.7 billion healthcare business of GE
(NYSE: GE). As a leading global medical technology, pharmaceutical
diagnostics and digital solutions innovator, GE Healthcare enables
clinicians to make faster, more informed decisions through
intelligent devices, data analytics, applications, and services,
supported by its Edison intelligence platform. With over 100 years
of healthcare industry experience and around 48,000 employees
globally, the company operates at the center of an ecosystem
working toward precision health, digitizing healthcare, helping
drive productivity and improve outcomes for patients, providers,
health systems and researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, and Insights for the
latest news, or visit our website www.gehealthcare.com for more
information.
i “Global Procedure Volumes and Reimbursement for MRI Equipment
Growth Opportunities: Portable Point-of-Care Systems and Increase
in Cardiac and Neuro Imaging Accelerated MRI Procedures across
Regions.” Frost & Sullivan. Published February 2022.
PCB7-50.
ii GE Healthcare data on file
iii AIR Recon DL 3D and PROPELLER is 510(k) pending at the FDA.
Not CE marked. Not available for sale in the United States or EU.
Not commercially available in all markets.
iv Gleeson, Cailey. “Healthcare staff shortages project for
every state by 2026.” Becker’s Hospital Review. Published 29
September 2021. Accessed 24 November 2021.
https://www.beckershospitalreview.com/workforce/healthcare-staff-shortages-projected-for-every-state-by-2026-4-report-findings.html
v Levine, David. “U.S. Faces Crisis of Burned-Out Health Care
Workers.” U.S. News & World Report. Published 15 November 2021.
Accessed 24 November 2021.
https://www.usnews.com/news/health-news/articles/2021-11-15/us-faces-crisis-of-burned-out-health-care-workers
vi “Prostate Cancer Statistics.” World Cancer Research Fund
International. Accessed 2 May 2022.
https://www.wcrf.org/cancer-trends/prostate-cancer-statistics/
vii MotionFree Brain is not CE Marked. May not be placed on
market nor put into service before it complies with CE marking. Not
commercially available in all markets.
viii SIGNA Artist Evo is not yet CE Marked. May not be placed on
market nor put into service before it complies with CE marking. Not
commercially available in all markets.
ix Based on historical ROI of full system upgrades vs. full
replacement.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220506005479/en/
Media Contacts: Margaret Steinhafel Chicago
Margaret.Steinhafel@ge.com +1 608 381 8829
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Mar 2024 to Apr 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2023 to Apr 2024